Saturday, February 25, 2023 2:12:10 PM
Bliueheel1 , yes I know you for that long from this MB already.
WOW , time really go quickly !!!!
I agree with you on all points except removal of hold in couple of weeks .
And I hope that I am wrong !!!
I really , really hoped for end of February ,
Look this will not happen ,
I am sure you know that each time CYDY send all the papers to FDA , and they will have a little question to us , and why not to have it if one want to delay , it takes another up to 30 calendar days for FDA to legally respond to us..
I also learned during this pandemic that FDA only is working hard to approve these toxic drugs with low efficacy from BP , like remdesivir , it took FDA all 2-3 days after Dr Fauci asked them to give EUA ,
but not a wonderful , safe drug with high efficacy , from small biotech like leronlimab
Then they evaluating each subgroup of dying people if it is important enough to look at them ,,,hmmm
So I figure it will take them at least 2-3 rounds of questions and answers before approval ,
So possibly end of March or April , or if BP tell them , maybe later ..
And for the short to come and make a comment ..
" next year CytoDyn will not be existing " .. I may only think of one reason for this to happen , a BO ..
For a proper price , I will take it.
My best..
All IMO.
GLTA longs..
WOW , time really go quickly !!!!
I agree with you on all points except removal of hold in couple of weeks .
And I hope that I am wrong !!!
I really , really hoped for end of February ,
Look this will not happen ,
I am sure you know that each time CYDY send all the papers to FDA , and they will have a little question to us , and why not to have it if one want to delay , it takes another up to 30 calendar days for FDA to legally respond to us..
I also learned during this pandemic that FDA only is working hard to approve these toxic drugs with low efficacy from BP , like remdesivir , it took FDA all 2-3 days after Dr Fauci asked them to give EUA ,
but not a wonderful , safe drug with high efficacy , from small biotech like leronlimab
Then they evaluating each subgroup of dying people if it is important enough to look at them ,,,hmmm
So I figure it will take them at least 2-3 rounds of questions and answers before approval ,
So possibly end of March or April , or if BP tell them , maybe later ..
And for the short to come and make a comment ..
" next year CytoDyn will not be existing " .. I may only think of one reason for this to happen , a BO ..
For a proper price , I will take it.
My best..
All IMO.
GLTA longs..
Bullish
Recent CYDY News
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
- CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer • GlobeNewswire Inc. • 01/27/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/09/2026 10:15:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/09/2026 01:30:45 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/22/2025 10:15:23 PM
